Market Research

Europe Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 149 Pages Knowledge Based Value (KBV) Research April, 2025 KBV20010371
Best Price Guarantee
Price from $1,500
Length 149 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date April, 2025
SKU KBV20010371

The Europe Computational Pathology Market would witness market growth of 7.7% CAGR during the forecast period (2025-2032).

The Germany market dominated the Europe Computational Pathology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $74.3 million by 2032. The UK market is exhibiting a CAGR of 6.7% during (2025 - 2032). Additionally, The France market would experience a CAGR of 8.4% during (2025 - 2032).

Traditional pathology involves examining physical tissue slides under a microscope, which is time-consuming and relies on the pathologist's subjective interpretation. These pathology employs AI and machine learning algorithms to analyze digital pathology images, identifying patterns and abnormalities in tissue samples that the human eye might miss.

The most prominent application of these pathology lies in the diagnosis and prognosis of cancer. Pathologists can use advanced image analysis tools to study digital slides of tissue biopsies, enabling early detection of cancerous cells, monitoring disease progression, and predicting treatment outcomes. Algorithms can assess features such as tumour size, shape, and texture, providing valuable insights into the malignancy of the tumour.

The market in the region is witnessing robust growth, driven by the increasing prevalence of chronic diseases, rising healthcare investments, and the region’s strong focus on research and development (R&D). As countries strive to modernize healthcare delivery and improve diagnostic accuracy, computational pathology—which leverages AI and digital imaging for advanced disease diagnosis—is gaining traction across hospitals, research institutes, and diagnostic labs. Trends in Belgium, the broader European Union (EU), and the United Kingdom (UK) influence the market’s upward trajectory. Belgium stands out as a European leader in research, with $1.64 billion (€1.5 billion) spent annually on R&D, representing 40% of all private investment in the country. This high level of investment creates a fertile ecosystem for developing and implementing cutting-edge healthcare technologies, including computational pathology. The strong collaboration between academia, industry, and healthcare providers in Belgium facilitates innovation in digital diagnostics. As R&D initiatives increasingly focus on personalized medicine and AI-powered diagnostics, computational pathology is expected to see growing adoption for both clinical and research applications. In conclusion, Belgium’s R&D leadership, the EU’s pressing health challenges, and the UK’s growing healthcare investment are converging to drive the rapid adoption of these pathology technologies across Europe.

Based on Component, the market is segmented into Software and Services. Based on Application, the market is segmented into Disease Diagnosis, Drug Discovery & Development, and Academic Research. Based on End-use, the market is segmented into Hospitals and Diagnostic Labs, Biotechnology & Pharmaceutical Companies, Academic and Research Institutes, and Other End-use. Based on Technology, the market is segmented into Machine Learning (ML), (Deep Learning and Other Machine Learning (ML)), Computer Vision, Natural Language Processing (NLP) Models, and Other Technology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • PathAI, Inc.
  • Hamamatsu Photonics K.K.
  • Olympus Corporation
  • Visiopharm A/S
  • Mikroscan Technologies, Inc.
  • MindPeak GmbH
  • Indica Labs, LLC
  • Nucleai, Inc. (Nucleai)
Europe Computational Pathology Market Report Segmentation

By Component
  • Software
  • Services
By Application
  • Disease Diagnosis
  • Drug Discovery & Development
  • Academic Research
By End-use
  • Hospitals and Diagnostic Labs
  • Biotechnology & Pharmaceutical Companies
  • Academic and Research Institutes
  • Other End-use
By Technology
  • Machine Learning (ML)
  • Deep Learning
  • Other Machine Learning (ML)
  • Computer Vision
  • Natural Language Processing (NLP) Models
  • Other Technology
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Computational Pathology Market, by Component
1.4.2 Europe Computational Pathology Market, by Application
1.4.3 Europe Computational Pathology Market, by End-use
1.4.4 Europe Computational Pathology Market, by Technology
1.4.5 Europe Computational Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Mar – 2025, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Computational Pathology Market by Component
5.1 Europe Software Market by Country
5.2 Europe Services Market by Country
Chapter 6. Europe Computational Pathology Market by Application
6.1 Europe Disease Diagnosis Market by Country
6.2 Europe Drug Discovery & Development Market by Country
6.3 Europe Academic Research Market by Country
Chapter 7. Europe Computational Pathology Market by End-use
7.1 Europe Hospitals and Diagnostic Labs Market by Country
7.2 Europe Biotechnology & Pharmaceutical Companies Market by Country
7.3 Europe Academic and Research Institutes Market by Country
7.4 Europe Other End-use Market by Country
Chapter 8. Europe Computational Pathology Market by Technology
8.1 Europe Machine Learning (ML) Market by Country
8.2 Europe Computational Pathology Market by Machine Learning (ML) Type
8.2.1 Europe Deep Learning Market by Country
8.2.2 Europe Other Machine Learning (ML) Market by Country
8.3 Europe Computer Vision Market by Country
8.4 Europe Natural Language Processing (NLP) Models Market by Country
8.5 Europe Other Technology Market by Country
Chapter 9. Europe Computational Pathology Market by Country
9.1 Germany Computational Pathology Market
9.1.1 Germany Computational Pathology Market by Component
9.1.2 Germany Computational Pathology Market by Application
9.1.3 Germany Computational Pathology Market by End-use
9.1.4 Germany Computational Pathology Market by Technology
9.1.4.1 Germany Computational Pathology Market by Machine Learning (ML) Type
9.2 UK Computational Pathology Market
9.2.1 UK Computational Pathology Market by Component
9.2.2 UK Computational Pathology Market by Application
9.2.3 UK Computational Pathology Market by End-use
9.2.4 UK Computational Pathology Market by Technology
9.2.4.1 UK Computational Pathology Market by Machine Learning (ML) Type
9.3 France Computational Pathology Market
9.3.1 France Computational Pathology Market by Component
9.3.2 France Computational Pathology Market by Application
9.3.3 France Computational Pathology Market by End-use
9.3.4 France Computational Pathology Market by Technology
9.3.4.1 France Computational Pathology Market by Machine Learning (ML) Type
9.4 Russia Computational Pathology Market
9.4.1 Russia Computational Pathology Market by Component
9.4.2 Russia Computational Pathology Market by Application
9.4.3 Russia Computational Pathology Market by End-use
9.4.4 Russia Computational Pathology Market by Technology
9.4.4.1 Russia Computational Pathology Market by Machine Learning (ML) Type
9.5 Spain Computational Pathology Market
9.5.1 Spain Computational Pathology Market by Component
9.5.2 Spain Computational Pathology Market by Application
9.5.3 Spain Computational Pathology Market by End-use
9.5.4 Spain Computational Pathology Market by Technology
9.5.4.1 Spain Computational Pathology Market by Machine Learning (ML) Type
9.6 Italy Computational Pathology Market
9.6.1 Italy Computational Pathology Market by Component
9.6.2 Italy Computational Pathology Market by Application
9.6.3 Italy Computational Pathology Market by End-use
9.6.4 Italy Computational Pathology Market by Technology
9.6.4.1 Italy Computational Pathology Market by Machine Learning (ML) Type
9.7 Rest of Europe Computational Pathology Market
9.7.1 Rest of Europe Computational Pathology Market by Component
9.7.2 Rest of Europe Computational Pathology Market by Application
9.7.3 Rest of Europe Computational Pathology Market by End-use
9.7.4 Rest of Europe Computational Pathology Market by Technology
9.7.4.1 Rest of Europe Computational Pathology Market by Machine Learning (ML) Type
Chapter 10. Company Profiles
10.1 Koninklijke Philips N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 PathAI, Inc.
10.3.1 Company Overview
10.3.2 Recent strategies and developments:
10.3.2.1 Partnerships, Collaborations, and Agreements:
10.3.2.2 Product Launches and Product Expansions:
10.3.3 SWOT Analysis
10.4 Hamamatsu Photonics K.K.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 SWOT Analysis
10.5 Olympus Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 SWOT Analysis
10.6 Visiopharm A/S
10.6.1 Company Overview
10.6.2 Recent strategies and developments:
10.6.2.1 Partnerships, Collaborations, and Agreements:
10.6.2.2 Product Launches and Product Expansions:
10.6.3 SWOT Analysis
10.7 Mikroscan Technologies, Inc.
10.7.1 Company Overview
10.8 MindPeak GmbH
10.8.1 Company Overview
10.8.2 Recent strategies and developments:
10.8.2.1 Partnerships, Collaborations, and Agreements:
10.9 Indica Labs, Inc.
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.3 SWOT Analysis
10.10. Nucleai, Inc. (Nucleai)
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Partnerships, Collaborations, and Agreements:

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings